Trial Profile
A phase 1 study of MVA-BN HPV + AdVac
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 May 2018
Price :
$35
*
At a glance
- Drugs HIV vaccine (Primary) ; MVA BN human papillomavirus vaccine (Primary)
- Indications Human papillomavirus infections
- Focus Adverse reactions
- 30 May 2018 New trial record
- 24 May 2018 According to a Bavarian Nordic media release, the company has planned to initiate this study in H2, 2018.